Title : Metformin reverses multidrug resistance in human hepatocellular carcinoma Bel‑7402/5‑fluorouracil cells.

Pub. Date : 2014 Dec

PMID : 25310259






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Metformin targeted the AMP-activated protein kinase (AMPK)/mammalian target of rapamycin (mTOR) pathway, suppressed the expression of hypoxia-inducible factor-1alpha (HIF-1alpha) and transcriptionally downregulated the expression of multidrug resistance protein 1/P-glycoprotein (P-gp) and multidrug resistance-associated protein 1 (MRP1). Metformin hypoxia inducible factor 1 subunit alpha Homo sapiens
2 Metformin targeted the AMP-activated protein kinase (AMPK)/mammalian target of rapamycin (mTOR) pathway, suppressed the expression of hypoxia-inducible factor-1alpha (HIF-1alpha) and transcriptionally downregulated the expression of multidrug resistance protein 1/P-glycoprotein (P-gp) and multidrug resistance-associated protein 1 (MRP1). Metformin hypoxia inducible factor 1 subunit alpha Homo sapiens
3 Collectively, these findings suggested that metformin may target the AMPK/mTOR/HIF-1alpha/P-gp and MRP1 pathways to reverse MDR in hepatocellular carcinoma. Metformin hypoxia inducible factor 1 subunit alpha Homo sapiens